Cutaneous ulceration in dermatomyositis: Association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease

Arthritis Care and Research

Volumn 67, Issue 5, 2015, Pages 667-672

  Narang, Neera S ^a   Casciola Rosen, Livia ^b   Li, Shufeng ^a   Chung, Lorinda ^a,c   Fiorentino, David F ^a  

^a STANFORD UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; MELANOMA DIFFERENTIATION ASSOCIATED GENE 5 ANTIBODY; UNCLASSIFIED DRUG; DEAD BOX PROTEIN; IFIH1 PROTEIN, HUMAN;

ADULT; ARTICLE; ASIAN; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOMYOSITIS; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; HUMAN; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; SKIN ULCER; ASIAN AMERICAN; BLOOD; CHI SQUARE DISTRIBUTION; COMPLICATION; EPIDEMIOLOGY; ETHNOLOGY; IMMUNOLOGY; LUNG DISEASES, INTERSTITIAL; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK FACTOR; STATISTICAL MODEL; UNITED STATES;

ADULT; ASIAN AMERICANS; AUTOANTIBODIES; CALIFORNIA; CHI-SQUARE DISTRIBUTION; DEAD-BOX RNA HELICASES; DERMATOMYOSITIS; FEMALE; HUMANS; LOGISTIC MODELS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN ULCER;

EID: 84928566189     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22498     Document Type: Article

References (27)

1. Ponyi A, Constantin T, Garami M, Andras C, Tallai B, Vancsa A, et al. Cancer-associated myositis: clinical features and prognostic signs. Ann N Y Acad Sci 2005; 1051: 64-71.
2. Fathi M, Lundberg IE, Tornling G., Pulmonary complications of polymyositis and dermatomyositis. Semin Respir Crit Care Med 2007; 28: 451-8.
3. Sontheimer RD., Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin 2002; 20: 387-408.
4. Goreshi R, Chock M, Foering K, Feng R, Okawa J, Rose M, et al. Quality of life in dermatomyositis. J Am Acad Dermatol 2011; 65: 1107-16.
5. Feldman D, Hochberg MC, Zizic TM, Stevens MB., Cutaneous vasculitis in adult polymyositis/dermatomyositis. J Rheumatol 1983; 10: 85-9.
6. Kono H, Inokuma S, Nakayama H, Suzuki M., Pneumomediastinum in dermatomyositis: association with cutaneous vasculopathy. Ann Rheum Dis 2000; 59: 372-6.
7. Yamasaki Y, Yamada H, Ohkubo M, Yamasaki M, Azuma K, Ogawa H, et al. Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan. J Rheumatol 2011; 38: 1636-43.
8. Yosipovitch G, Feinmesser M, David M., Adult dermatomyositis with livedo reticularis and multiple skin ulcers. J Eur Acad Dermatol Venereol 1998; 11: 48-50.
9. Tsujimura S, Saito K, Tanaka Y., Complete resolution of dermatomyositis with refractory cutaneous vasculitis by intravenous cyclophosphamide pulse therapy. Intern Med 2008; 47: 1935-40.
10. Mautner GH, Grossman ME, Silvers DN, Rabinowitz A, Mowad CM, Johnson BL Jr., Epidermal necrosis as a predictive sign of malignancy in adult dermatomyositis. Cutis 1998; 61: 190-4.
11. Mahe E, Descamps V, Burnouf M, Crickx B., A helpful clinical sign predictive of cancer in adult dermatomyositis: cutaneous necrosis [commentary]. Arch Dermatol 2003; 139: 539.
12. Kim HJ, Hong YK, Yoo WH., Dermatomyositis, complicated with pneumomediastinum, successfully treated with cyclosporine A: a case report and review of literature. Rheumatol Int 2009; 29: 1101-4.
13. Gunawardena H, Betteridge ZE, McHugh NJ., Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology (Oxford) 2009; 48: 607-12.
14. Cao H, Pan M, Kang Y, Xia Q, Li X, Zhao X, et al. Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody. Arthritis Care Res (Hoboken) 2012; 64: 1602-10.
15. Chaisson NF, Paik J, Orbai AM, Casciola-Rosen L, Fiorentino D, Danoff S, et al. A novel dermato-pulmonary syndrome associated with MDA-5 antibodies: report of 2 cases and review of the literature. Medicine (Baltimore) 2012; 91: 220-8.
16. Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L., The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol 2011; 65: 25-34.
17. Bohan A, Peter J., Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-7.
18. Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD., A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of idiopathic inflammatory myopathies. J Am Acad Dermatol 2006; 54: 597-613.
19. Fiorentino DF, Chung LS, Christopher-Stine L, Zaba L, Li S, Mammen AL, et al. Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ. Arthritis Rheum 2013; 65: 2954-62.
20. Cicuttini FM, Fraser KJ., Recurrent pneumomediastinum in adult dermatomyositis. J Rheumatol 1989; 16: 384-6.
21. Yamamoto T, Ohkubo H, Katayama I, Nishioka K., Dermatomyositis with multiple skin ulcers showing vasculitis and membrano-cystic lesion. J Dermatol 1994; 21: 687-9.
22. Crowson AN, Magro CM., The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis. Hum Pathol 1996; 27: 15-9.
23. Funauchi M, Shimadsu H, Tamaki C, Yamagata T, Nozaki Y, Sugiyama M, et al. Role of endothelial damage in the pathogenesis of interstitial pneumonitis in patients with polymyositis and dermatomyositis. J Rheumatol 2006; 33: 903-6.
24. Kawakami T, Mizoguchi M, Saito R, Soma Y., Histopathological evidence of small-vessel vasculitis within the skin and lungs associated with interstitial pneumonia in an adult patient with dermatomyositis. Clin Exp Dermatol 2008; 33: 415-7.
25. Magro CM, Ross P, Marsh CB, Allen JN, Liff D, Knight DA, et al. The role of anti-endothelial cell antibody-mediated microvascular injury in the evolution of pulmonary fibrosis in the setting of collagen vascular disease. Am J Clin Pathol 2007; 127: 237-47.
26. Bradley JD., Spontaneous pneumomediastinum in adult dermatomyositis. Ann Rheum Dis 1986; 45: 780-2.
27. Carmody E, McNicholl J, Chadwick G, Bresnihan B, Fitzgerald MX., Prolonged spontaneous pneumomediastinum in adult dermatomyositis. Ann Rheum Dis 1987; 46: 566.